NexPoint Life Sciences II DST
NexPoint Life Sciences II DST is a real estate fund based in Dallas, Texas. According to its most recent Form D, filed Nov 20, 2025, it has sold $40,489,695 of interests to 112 investors since its first sale in Jun 2023. The minimum investment it accepts from an outside investor is $100,000. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include NREA Life Sciences II, LLC; NREA LS II Investment Co, LLC; Matt McGraner.
- Total raised
- $40,489,695Cumulative sales reported on Form D
- Investors
- 112
- First sale
- Jun 20, 2023
- Minimum investment
- $100,000
- Who can invest
- Not stated
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- NREA Life Sciences II, LLC; NREA LS II Investment Co, LLC; Matt McGraner
- Latest Form D
- Nov 20, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about NexPoint Life Sciences II DST
What is the minimum investment for NexPoint Life Sciences II DST?
According to its latest Form D, filed Nov 20, 2025, the minimum investment NexPoint Life Sciences II DST accepts from an outside investor is $100,000.
Who can invest in NexPoint Life Sciences II DST?
NexPoint Life Sciences II DST is generally open only to investors who meet the eligibility rules in its offering documents. It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has NexPoint Life Sciences II DST raised?
NexPoint Life Sciences II DST reports $40,489,695 sold from 112 investors on its Form D filed Nov 20, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is NexPoint Life Sciences II DST based?
NexPoint Life Sciences II DST is based in Dallas, Texas.
When did NexPoint Life Sciences II DST launch?
NexPoint Life Sciences II DST reports its first sale in Jun 2023, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every real estate fund
Raised more than 96% of the 1,414 real estate funds based in Texas, and more than 93% of all 7,321 that report sales.